Cart
sales@molnova.com
Galiximab
CAS No. 357613-77-5
Galiximab( —— )
Catalog No. M36728 CAS No. 357613-77-5
Galiximab (IDEC 114), a primatized IgG1 lambda monoclonal antibody, targets the CD80 antigen.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 375 | Get Quote |
|
| 5MG | 687 | Get Quote |
|
| 10MG | 937 | Get Quote |
|
| 25MG | 1371 | Get Quote |
|
| 50MG | 1812 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGaliximab
-
NoteResearch use only, not for human use.
-
Brief DescriptionGaliximab (IDEC 114), a primatized IgG1 lambda monoclonal antibody, targets the CD80 antigen.
-
DescriptionGaliximab (IDEC 114) is a primatized immunoglobulin G1 (IgG1) lambda monoclonal antibody directed against the CD80 antigen. Galiximab has variable regions are primatized (cynomologous monkeys), and the constant regions are human. Galiximab can be used in research of B-cell lymphoma.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number357613-77-5
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Smith SM, et, al. The anti-CD80 primatized monoclonal antibody, galiximab, is well-tolerated but has limited activity in relapsed Hodgkin lymphoma: Cancer and Leukemia Group B 50602 (Alliance). Leuk Lymphoma. 2013 Jul;54(7):1405-10.?
molnova catalog
related products
-
Ibutamoren
Ibutamoren is a drug which acts as a potent, orally active growth hormone secretagogue, mimicking the GH stimulating action of the endogenous hormone ghrelin.
-
Glucocapparin
The herbs of Capparis spinosa L.
-
Matairesinol
Matairesinol has radical and superoxide scavenging activities; it also has anti-angiogenic activity by suppressing mROS signaling , can decrease hypoxia-inducible factor-1α± in hypoxic HeLa cells.
